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Abstract: Real-time PCR (rPCR) is a widely accepted diagnostic tool for the detection and
quantification of nucleic acid targets. In order for these assays to achieve high sensitivity and
specificity, primer and probe-template complementarity is essential; however, mismatches are often
unavoidable and can result in false-negative results and errors in quantifying target sequences.
Primer and probe sequences therefore require continual evaluation to ensure they remain fit for
purpose. This paper describes the development of a linear model and associated computational
tool (GoPrime) designed to predict the performance of rPCR primers and probes across multiple
sequence data. Empirical data were generated using DNA oligonucleotides (n = 90) that systematically
introduced variation in the primer and probe target regions of a diagnostic assay routinely used
to detect foot-and-mouth disease virus (FMDV); an animal virus that exhibits a high degree of
sequence variability. These assays revealed consistent impacts of patterns of substitutions in primer
and probe-sites on rPCR cycle threshold (CT) and limit of detection (LOD). These data were used
to populate GoPrime, which was subsequently used to predict rPCR results for DNA templates
(n = 7) representing the natural sequence variability within FMDV. GoPrime was also applicable to
other areas of the FMDV genome, with predictions for the likely targets of a FMDV-typing assay
consistent with published experimental data. Although further work is required to improve these
tools, including assessing the impact of primer-template mismatches in the reverse transcription step
and the broader impact of mismatches for other assays, these data support the use of mathematical
models for rapidly predicting the performance of rPCR primers and probes in silico.
Keywords: PCR; foot-and-mouth disease; diagnostics; in silico modeling framework
1. Introduction
Real-time PCR (rPCR) has become an essential tool in molecular biology and is routinely used
for detection, quantification, and differentiation of nucleic acids in both research and diagnostic
settings [1–3]. Central to the specificity and sensitivity of rPCR assays are the primers and probes,
with amplification affected by factors such as primer and probe-template complementarity and the
presence of secondary structures (e.g., primer dimers) [4]. However, designing primers and probes
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with full sequence complementarity to all the required targets can be problematic. For instance,
when considering RNA viruses such as foot-and-mouth disease virus (FMDV), the high mutation
rate (in the range of 10−3 to 10−5 per nucleotide site, per genome replication [5,6]) can result in fully
conserved regions being too short to accommodate primer and probe sets. This is especially true when
designing assays to target the more varied genomic regions for serotype/strain differentiation [7–10].
Consequently, primer and probe-template mismatches are often unavoidable and a compromise
approach that accommodates sequence mismatches is often adopted to design diagnostic tests.
The effects of mismatches on PCR amplification have been well studied and quantified for both
primers [11–22] and probes [20,21]. For instance, primer-template mismatches in the 3′-end region
of the primer have been shown to have a larger effect on PCR amplification than those located
towards the 5′-end, due to disruption of the DNA polymerase active site [11,16,18,20,22]. Furthermore,
for rPCR probes, the position of mismatches in the oligonucleotide have been shown to differentially
destabilize probe annealing [20].
Primer and probe-template mismatches can be especially problematic when considering the
use of rPCR for diagnostic purposes. By impacting rPCR amplification, mismatches can alter the
cycle threshold (CT) at which targets are detected, leading to errors in nucleic acid quantification.
For instance, a single internally located mismatch can result in up to a 1000-fold underestimation of
initial copy number [18]. Notably, mismatches at the 3′-end of primers have been shown to produce
effects ranging from a two-fold underestimation of initial copy number to complete prevention of
amplification, thus leading to false-negative results [22]. As such, false-negative rPCR results may be
common, especially in the instance of assays detecting lower viral loads (for FMDV, this is common in
oesophageal–pharyngeal fluid and environmental samples).
These effects of mismatches result in the requirement for continual evaluation of primer and probe
sequences. In addition to laborious manual laboratory-based screening, primer and probe validation
traditionally occurs though Basic Local Alignment Search Tool (BLAST) searches against publicly
available sequences [23], with tools now developed to automate the process [24–26]. However, despite
numerous studies into the effects of mismatches, no primer evaluation programs to date have been
developed using experimental data, with target sequences only reported as putative hits or misses.
With rPCR assays requiring different performance criteria depending upon their use, the provision of
binary predictions is limited. For example, high specificity is paramount for assays used to differentiate
between diseases, high sensitivity is required for assays used to confirm negative results and an
awareness of cross-reactivity is important for assays that distinguish between closely related sequences,
such as FMDV serotypes and viral lineages [9]. As such, the availability of a quantitative primer/probe
validation program could support rPCR evaluation by giving researchers and diagnosticians the ability
to rapidly predict whether assays are fit for purpose.
This paper describes the impacts of different primer and probe-template mismatches on CT and
limit of detection (LOD) on rPCR, and the presentation of a primer and probe evaluation framework
(GoPrime), in order to ascertain to what extent the effect of mismatches on template cDNA can be
predicted. Further analysis is required to assess the effects of primer-template mismatches during the
reverse transcription step.
2. Materials and Methods
2.1. The Effects of Primer and Probe-Template Mismatches
For all experimental analyses, primer sequences were kept the same and the template sequences
were varied. The primer and probe sequences, published by Callahan et al. (2002), were as
follows: forward primer: 5′-ACT GGG TTT TAC AAA CCT GTG A-3′ (Tm: 56.5 ◦C); reverse primer,
5′-GCG AGT CCT GCC ACG GA-3′ (Tm: 60 ◦C); and probe 5′-(6FAM)TCC TTT GCA CGC CGT
GGG AC(TAMRA)-3′ [27] (Tm calculated at www.eurofinsgenomics.eu/en/ecom/tools/oligo-analysis/).
Linear DNA oligonucleotide templates of 109 bp (Sigma-Aldrich, Munich, Germany) were designed
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around the cDNA target region for a published assay [27]: a conserved region of the FMDV genome
(3Dpol-coding region). Ninety templates were ordered, each designed to evaluate the consequences
of different variations in the primer or probe binding regions (Table 1). For example, variations
across the length of the primer and probe target regions were designed to investigate the effect of
position, with different bases substituted to study the effects of mismatch type and mismatch quantity.
Sequences were based on FMDV O/UKG/35/2001 (accession number KR265074, nucleotides 7862-7970).
In addition, a template with full primer/probe-template complementarity was ordered and used as the
reference template (R) for all rPCR runs.
Table 1. Linear DNA oligonucleotide templates for real-time PCR targets (5′-3′).
Forward Primer Target Probe Target Reverse Primer Target
R ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
1 ACTGGGTTTTACAAACCTGTGG TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
2 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC CCCGTGGCAGGACTCGC
3 ACTGGGTTTTACAAACCTGTGG TCCTTTGCACGCCGTGGGAC CCCGTGGCAGGACTCGC
4 ACTGGGTTTTACAAACCTGTGC TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
5 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC GCCGTGGCAGGACTCGC
6 ACTGGGTTTTACAAACCTGTGC TCCTTTGCACGCCGTGGGAC GCCGTGGCAGGACTCGC
7 ACTGGGTTTTACAAACCTATAA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
8 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TTCATGGCAGGACTCGC
9 ACTGGGTTTTACAAACCTATAA TCCTTTGCACGCCGTGGGAC TTCATGGCAGGACTCGC
10 ACTGGGTTTTACAAACCTTTTA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
11 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TACTTGGCAGGACTCGC
12 ACTGGGTTTTACAAACCTTTTA TCCTTTGCACGCCGTGGGAC TACTTGGCAGGACTCGC
13 ACTGGATTCTACGAACTTGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
14 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCCGTAGCGGGACTTGC
15 ACTGGATTCTACGAACTTGTGA TCCTTTGCACGCCGTGGGAC TCCGTAGCGGGACTTGC
16 ACTGGTTTGTACCAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
17 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCCGGACTAGC
18 ACTGGTTTGTACCAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCCGGACTAGC
19 ATTAGATTCTGCGAACTTGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
20 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCCGTAGCGGGGCTTGT
21 ATTAGATTCTGCGAACTTGTGA TCCTTTGCACGCCGTGGGAC TCCGTAGCGGGGCTTGT
22 AATTGTTTGTCCCAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
23 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCCGGCCTAGA
24 AATTGTTTGTCCCAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCCGGCCTAGA
25 AATAGTTTCTCCGAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
26 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCGGGCCTTGA
27 AATAGTTTCTCCGAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCGGGCCTTGA
28 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
29 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCGGGACTTGC
30 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCGGGACTTGC
31 ACTGGTTTTTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCGGGACTTGC
32 ACTGGTTTTTACAAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCAGGACTTGC
33 ACTGGTTTTTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCAGGACTCGC
34 ACTGGTTTTTACAAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
35 ACTGGGTTTTACAAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCAGGACTCGC
36 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC CCCGTGGCAGGACTCGC
37 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC GCCGTGGCAGGACTCGC
38 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TTCGTGGCAGGACTCGC
39 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TACGTGGCAGGACTCGC
40 ACTGGTTTTTACAAACATGTGA TCCTTTGCACGCCGTGGGAC CCCGTGGCAGGACTCGC
28 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
29 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCGGGACTTGC
30 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCGGGACTTGC
31 ACTGGTTTTTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCGGGACTTGC
32 ACTGGTTTTTACAAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCAGGACTTGC
33 ACTGGTTTTTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCAGGACTCGC
34 ACTGGTTTTTACAAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
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Table 1. Cont.
Forward Primer Target Probe Target Reverse Primer Target
35 ACTGGGTTTTACAAACATGTGA TCCTTTGCACGCCGTGGGAC TCCGTTGCAGGACTCGC
36 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC CCCGTGGCAGGACTCGC
37 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC GCCGTGGCAGGACTCGC
38 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TTCGTGGCAGGACTCGC
39 ACTGGTTTCTACGAACATGTGA TCCTTTGCACGCCGTGGGAC TACGTGGCAGGACTCGC
40 ACTGGTTTTTACAAACATGTGA TCCTTTGCACGCCGTGGGAC CCCGTGGCAGGACTCGC
41 ACTGGTTTTTACAAACATGTGA TCCTTTGCACGCCGTGGGAC GCCGTGGCAGGACTCGC
42 ACTGGGTTTTACAAACCTGAGG TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
43 ACTGGGTTTTACAAACCTGCGG TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
44 ACTGGGTTTTACAAACCTGAGC TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
45 ACTGGGTTTTACAAACCTGTTG TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
46 ACTGGGTTTTACAAACCTGTAG TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
47 ACTGGGTTTTACAAACCTGTTC TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
48 ACTGGGTTTTACAAACCTGGAA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
49 ACTGGGTTTTACAAACCTGCAA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
50 ACTGGGTTTTACAAACCTGGTA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
51 ACTGGGTTTTACAAACCTTTGG TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
52 ACTGGGTTTTACAAACCTATGG TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
53 ACTGGGTTTTACAAACCTTTGC TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
54 ACTGGGTTTTACAAACCTGTAA TCCTTTGCACGCCGTGGGAC TTCGTGGCAGGACTCGC
55 ACTGGGTTTTACAAACCTGTTA TCCTTTGCACGCCGTGGGAC TACGTGGCAGGACTCGC
56 ACTGGGTTTTACAAACCTGTAA TCCTTTGCACGCCGTGGGAC TACGTGGCAGGACTCGC
57 ACTGGGTTTTACAAACCTATTA TCCTTTGCACGCCGTGGGAC TCTGTGGCAGGACTCGC
58 ACTGGGTTTTACAAACCTATTA TCCTTTGCACGCCGTGGGAC TCAGTGGCAGGACTCGC
59 ACTGGGTTTTACAAACCTATTA TCCTTTGCACGCCGTGGGAC CCCGTGGCAGGACTCGC
60 ACTGGGTTTTACAAACCTATTA TCCTTTGCACGCCGTGGGAC GCCGTGGCAGGACTCGC
61 ACTGGGTTTTACAAACCTGTGA TCCTTGGCGCACAGCGGTAC TCCGTGGCAGGACTCGC
62 ACTGGGTTTTACAAACCTGTGA TCCTTGGCGCACCGCGGTAC TCCGTGGCAGGACTCGC
63 ACTGGGTTTTACAAACCTGTGA TCCTTGGCACACCGCGGTAC TCCGTGGCAGGACTCGC
64 ACTGGGTTTTACAAACCTGTGA TCCTTGGCACACCGCGGGAC TCCGTGGCAGGACTCGC
65 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACACCGCGGGAC TCCGTGGCAGGACTCGC
66 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACACCGTGGGAC TCCGTGGCAGGACTCGC
67 ACTGGGTTTTACAAACCTGTGA CCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
68 ACTGGGTTTTACAAACCTGTGA GCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
69 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAT TCCGTGGCAGGACTCGC
70 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAA TCCGTGGCAGGACTCGC
71 ACTGGGTTTTACAAACCTGTGA GGCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
72 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGCT TCCGTGGCAGGACTCGC
73 ACTGGGTTTTACAAACCTGTGA CCATTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
74 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGTAT TCCGTGGCAGGACTCGC
75 ACTGGGTTTTACAAACCTGTGA TTCGTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
76 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGTGGC TCCGTGGCAGGACTCGC
77 ACTGGGTTTTACAAACCTGTGA CCCTTTGCACACCGCGGGAC TCCGTGGCAGGACTCGC
78 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACACCGCGGGAT TCCGTGGCAGGACTCGC
79 ACTGGGTTTTACAAACCTGTGA CACTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
80 ACTGGGTTTTACAAACCTGTGG TCCTTGGCACACCGCGGGAC TCCGTGGCAGGACTCGC
81 ACTGGGTTTTACAAACCTGTGG TCCTTTGCACACCGCGGGAC TCCGTGGCAGGACTCGC
82 ACTGGGTTTTACAAACCTGTGC TCCTTTGCACACCGCGGGAC TCCGTGGCAGGACTCGC
83 ACTGGGTTTTACAAACCTTTGG TCCTTTGCACACCGCGGGAC TCCGTGGCAGGACTCGC
84 ACTGGGTTTTACAAACCTGTGG CCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
85 ACTGGGTTTTACAAACCTGTGG TCCTTTGCACGCCGTGGGAT TCCGTGGCAGGACTCGC
86 ACTGGTTTTTACAAACATGTGA TCCTTTGCACACCGCGGGAC TCCGTTGCAGGACTTGC
87 ACTGGTTTTTACAAACATGTGA TCCTTTGCACACCGCGGGAC TCCGTGGCAGGACTCGC
88 ACTGGGTTTTACAAACATGTGA TCCTTTGCACACCGTGGGAC TCCGTTGCAGGACTCGC
89 ACTGGGTTTTACAAACATGTGA CCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
90 ACTGGGTTTTACAAACATGTGA TCCTTTGCACGCCGTGGGAT TCCGTGGCAGGACTCGC
The primer/probe target sequences of the 90 DNA templates (109 base pairs in length) in 5′-3′ orientation.
Non-target regions between the primer/probe targets were identical to O/UKG/35/2001 (accession number KR265074:
nucleotides 7862-7970). The black sequence (top row) represents the reference template (R); grey sequences represent
the varying DNA templates, black highlighted bases depict primer/probe-template mismatch sites.
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2.2. Real-Time PCR
rPCR reactions were performed using two Taq-based rPCR kits.:
(1) ExciteTM UF 2x Master Mix (ExciteTM UF) (Quantig Ltd., Camberley, UK), a Taq-based rPCR kit,
was selected as it required minimal reaction set-up, increasing the likelihood of assay variation
being attributed to target sequence differences rather than human variability. Reactions were
performed in a total of 20 µL, containing: 5 µL template, 10 µL 2x master mix, 50 nM ROX
reference dye, 1.6 µL of each primer (16 pmol), 1.2 µL of probe (6 pmol) (primers and probes final
concentrations as previously described [28]) and made up to volume with nuclease-free water
(NFW). Thermal cycling conditions were 95 ◦C for 3 min, followed by 50 cycles of 95 ◦C for 5 s
and 60 ◦C for 20 s.
(2) SuperScript™ III Platinum™One-Step qRT-PCR Kit (SSIIITM) (Thermo Fisher Scientific, Waltham,
MA, USA) was chosen as it is a commonly used Taq-based kit. Reagents, parameters, primer/probe
final concentrations and thermal cycling conditions were as previously reported [28]. Reactions
were performed in a total of 25 µL, containing: 5 µL template, 12.5 µL 2x buffer, 0.5 µL of
Superscript III enzyme mix (both supplied with the kit), 50 nM ROX reference dye, 2 µL of each
primer (20 pmol), 1.5 µL of probe (7.5 pmol) [27] and made up to volume with NFW. Thermal
cycling conditions were 95 ◦C for 10 min, followed by 50 cycles of 95 ◦C for 15 s and 60 ◦C for
1 min. The reverse transcription (RT) step was omitted from the published protocol [28].
All rPCR reactions were performed on an ABI ViiATM 7 real-time PCR system thermocycler
(Thermo Fisher Scientific). Positive reactions were defined as those that gave a detectable CT (no CT
cut-off set). Initial rPCR reactions were performed in duplicate using 106 copies of template. Where CT
values were detected, further rPCR reactions were performed in duplicate across a log10 dilution
series of template (106–100 copies/reaction) in 0.1 µg/µL carrier RNA (Ambion®, Austin, TX, USA,
Thermo Fisher Scientific, Waltham, MA, USA). The effect of mismatches on rPCR were determined by
calculating the change in CT (∆CT) and change in LOD (∆LOD) between the reference and varying
oligonucleotide DNA templates.
2.3. Development of GoPrime
In order to ascertain the effect of each primer and probe-template mismatch type on ∆CT and
∆LOD, linear model analysis was performed. Linear model variables (Table 2) were selected based on
statistical analysis (to ascertain which primer and probe-template mismatch locations were statistically
different from one another) and published data (Supplementary Data Table S1).




Percentage mismatch (forward and reverse combined)
Type 1 mismatch at the 3′-end (nucleotide 1)
Type 2 mismatch at the 3′-end (nucleotide 1)
Type 1 mismatch at the 3′-end (nucleotide 2)
Type 2 mismatch at the 3′-end (nucleotide 2)
Type 1 mismatch at the 3′-end (nucleotides 3-4)
Type 2 mismatch at the 3′-end (nucleotides 3-4)
Probe Percentage mismatch
Mismatches were grouped as one of two types: (type 1) purine-pyrimidine mismatch (G-T or C-A nucleotide
base pairing, leading to a minor conformational change in the primer/probe-template duplex); (type 2)
purine-purine or pyrimidine-pyrimidine mismatch (G-A, A-A, G-G, C-T, T-T or C-C nucleotide base pairing,
leading to a major conformational change in the primer/probe-template duplex).
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Linear model analysis [29] was performed in R [30], using the variables stated in Table 2, and all
quantitative data collected (90 templates, all template dilutions, using both Taq-based kits, to analyze
the average effects of mismatches [one linear model looked primer-template mismatches; a second
linear model was used to look at probe-template mismatches]). The results of the linear models were
used to parameterize GoPrime: a computational tool for predicting the effects of mismatches on rPCR.
GoPrime was built by implementing the primer and probe mismatch rules and CT penalties in a
computer program written in the Java programming language. GoPrime takes as input fasta sequence
files of the primers/probe and target sequences. It calculates an expected change in CT for each target
sequence set based on the number and type of mismatches between the primer/probe and template
present. The GoPrime program is freely available from: https://github.com/rjorton/GoPrime.
2.4. Evaluating GoPrime as a Predictor of rPCR Performance
In order to evaluate GoPrime on naturally occurring sequence variations, a search was performed
using the National Centre for Biotechnology Information (NCBI) nucleotide database (NCBI, 2017).
Seven FMDV sequences, which contained naturally occurring variations in the Callahan et al. (2002)
primer and probe target regions [27], were selected and ordered as linear DNA oligonucleotides of
109 bp (Table 3). These were used as template in rPCR, using both the ExciteTM UF and SSIIITM
protocols, with ∆CT and ∆LOD results compared with predictions from GoPrime.
Table 3. Linear DNA templates representing naturally occurring foot-and-mouth disease field isolates
for testing GoPrime predictions (5′-3′).
Forward Primer Target Probe Target Reverse Primer Target
R ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
JX040500 ACTGGGTTTTACAAACCTATGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
KC440884 ACTGGATTTTATAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
AY593802 ACTGGGTTTTACAAACCTGTGA TCCTTCGCACGCCGTGGGAC TCTGTGGCAGGGCTCGC
KC440883 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCTGTGGCGGGACTCGC
AY593812 ACTGGGTTTTACAAACCTGTGA TCCTTTGCACGCCGTGGGAC TCAGTGGCAGGACTCGC
KF112882 ACTGGGTTTTACAAACCTGTGA CCCTTTGCACGCCGTGGGAC TCCGTGGCAGGACTCGC
HM191257 ACTGGGTTTTACAAACCTGTGA TCCTTCGCACGCCGTGGGAC TCTGTGGCAGGACTCGC
The primer/probe binding regions of the seven DNA oligonucleotides ordered to test the program (109 base pairs in
length, with regions between primers consistent with the sequences for each accession number. The black sequence
(top row) represents the reference template (R); grey sequences represent the varying DNA templates, with black
highlighted bases depicting primer/probe-template mismatch sites. FMDV serotypes were as follows: JX040500 (O);
KC440884 (Southern African Territories 2); AY593802 (A); KC440883 (O); AY593812 (O); KF112882 (O); HM191257 (O).
In order to ascertain how transferable GoPrime was to other areas of the FMDV genome, GoPrime
was used to analyze four FMDV-typing assays designed to target the less conserved VP1/2A-coding
regions [9]. The four sets of primers and probes (specific for either serotype A, O, Southern African
Territories [SAT] 1 or SAT 2 field viruses circulating in East Africa) were evaluated against the
66 VP1/2A-coding sequences used in the initial laboratory-based evaluation (A = 15; O = 20; SAT 1 = 19;
SAT 2 = 12). The published experimental results [9] and GoPrime predictions for the likely targets
of each assay were then compared and displayed using GoPrimeTree. GoPrimeTree is a simple Java
program that takes an existing nexus tree of the target sequences, and adds FigTree [31] readable
coloring to the tree tips based on the GoPrime predicted ∆CT values; different shades of the colors
green, orange, and red were used to represent target sequences with ∆CT’s between 0–10, 10–20,
and 20–30, respectively, whilst black was used for sequences that failed to amplify.
2.5. Statistical and Phylogenetic Analysis
Statistical analyses were performed using R [30]. Phylogenetic trees for the visualization of
∆CT GoPrime results across FMDV serotypes were produced from sequence alignments in Mega
(version 7.0.21) [32] using the neighbor-joining method [33] and viewed in FigTree (version 1.4.3) [31].
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3. Results
3.1. The Effects of Primer/Probe-Template Mismatches on rPCR
For this assay, single mismatches between the template and the primer, at the 3′-end of the primer
(using both rPCR kits) had the most detrimental effect on CT (average ∆CT of between 6.38 and 11.57
across the dilution series) (Figure 1). Furthermore, the type of mismatch was shown to be important.
For instance, at the 3′-end of the reverse primer, a C-A mismatch (type 1 mismatch: purine-pyrimidine)
resulted in an average effect of ∆CT of 8.59 across the dilution series, whereas a G-A mismatch (type 2
mismatch: purine-purine or pyrimidine-pyrimidine) in the same location resulted in an average effect
of ∆CT of 11.57 across the dilution series (Figure 1A). Multiple mismatches in the 3′-end of the primers
(either (i) both in one primer or (ii) one the forward and one in the reverse primer) either prevented
amplification from occurring or required high template copy number (104–106 copies per reaction) for
any amplification to occur, depending on the mismatches (Figure 1B,C).Pathogens 2020, 9, x FOR PEER REVIEW 7 of 15 
 
 
Figure 1. The effects of primer-template mismatches on real-time PCR (rPCR) cycle threshold (CT). 
(A) single mismatches at the 3ʹ-end; (B) and (C) multiple mismatches at the 3ʹ-end(s); (D) effect of 
primer-template percentage complementary. Results represent the average increase in cycle threshold 
(ΔCT) from the reference template across two rPCR kits (ExciteTM UF 2x Master and SuperScript™ III 
Platinum™ One-Step qRT-PCR Kit) and a dilution series of template (106–100 copies/reaction). The 
limit of detection (LOD) for each template is defined as the lowest dilution where all replicates were 
positive (displayed in grey text). Error bars represent the standard deviation. (F) forward primer; (R) 
reverse primer; (nt) nucleotide. Template number refers to Table 1. 
Figure 1. The effects of primer-template mismatches on real-time PCR (rPCR) cycle threshold (CT).
(A) single mismatches at the 3′-end; (B) and (C) multiple mismatches at the 3′-end(s); (D) effect of
primer-template percentage co plementary. Results represent the average increase in cycle threshold
(∆CT) from he reference template across two rPCR kits (ExciteTM UF 2x Maste and SuperScript™ III
Platinum™One-Step qRT-PCR Kit) and a dilution series of template (106–100 copies/reaction). The limit
of detection (LOD) for each template is defined as the lowest dilution where all replicates were positive
(displayed in grey text). Error bars represent the standard deviation. (F) forward primer; (R) reverse
primer; (nt) nucleotide. Template number refers to Table 1.
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When studying the effect of primer-template percentage complementarity across the total length
of the primers, a minimum of 82.05% primer-template match between the forward and reverse primers
(combined) was required for amplification to occur (Figure 1D). When studying the effect of the
mismatches across the length of the probe, a minimum of 85% probe-template complementarity was
required in order for effective detection to occur, impacting upon rPCR ∆CT by 6.58 on average across
the dilution series (Figure 2).
Pathogens 2020, 9, x FOR PEER REVIEW 8 of 15 
 
 
Figure 2. The effects of probe-template mismatches on real-time PCR (rPCR) cycle threshold. Results 
represent the average increase in cycle threshold (CT) from a perfectly matched template, across two 
rPCR kits (ExciteTM UF 2x Master and SuperScript™ III Platinum™ One-Step qRT-PCR Kit) and a 
dilution series of template (106–100 copies/reaction). The limit of detection (LOD) for each template is 
defined as the lowest dilution where all replicates were positive (displayed in grey text). Error bars 
represent the standard deviation. (P) probe; percentages represent probe-template complementarity. 
Template number refers to Table 1. 
3.2. Development of GoPrime 
Using linear model analysis, the average effect of each primer and probe-template mismatch 
type was determined, accounting for both single and multiple mismatches in the primer and probe 
binding regions, by implementing additive and dampening effects where necessary (Table 4). These 
results from the linear model, the minimum match percentages (82.05% primers combined, 85% 
probe), combined maximum of 2 mutations at the 3ʹ end of primers, and ΔCT penalties for mutation 
types/combinations were used to parameterize the GoPrime program.  
To use GoPrime, users provide a file of their primer/probe sequences (5ʹ-3ʹ fasta format) and a 
file of template sequences to be analyzed (5ʹ-3ʹ fasta format). GoPrime first analyzes the template, in 
both orientations, for possible forward and reverse primer targets (Figure 3); at this stage, forward 
and reverse primers are analyzed individually to generate potential targets to investigate further as 
possible pairs. This is done based on the minimum requirements for primer-template 
complementarity, which were defined during data analysis (Table 4). Once possible forward and 
reverse primer targets are identified, they are evaluated as possible primer pairs (Figure 3). Potential 
probe targets (optional) are then identified between the primer pairs, searching again in both 
orientations based on the probe-template mismatch limits determined during data analysis (Table 4).  
Figure 2. The effects of probe-template mismatches on real-time PCR (rPCR) cycle threshold. Results
represent the average increase in cycle threshold (CT) from a perfectly matched template, across two
rPCR kits (ExciteTM UF 2x Master and SuperScript™ III Platinum™ One-Step qRT-PCR Kit) and a
dilution series of template (106–100 copies/reaction). The limit of detection (LOD) for each template is
defined as the lowest dilution where all replicates were positive (displayed in grey text). Error bars
represent the standar deviation. (P) probe; ercentages represent probe-template co plementarity.
Template number r fers to Table 1.
3.2. Development of GoPrime
Using l ear model analysis, the average eff ct of each primer and probe-template is type
was determined, accounting for both single and multiple mismatches in the prime and probe binding
regions, by implementing additive and dampening effects where necessary (Table 4). These results from
the linear model, the minimum match percentages (82.05% primers combined, 85% probe), combined
maximum of 2 mutations at the 3′ end of primers, and ∆CT penalties for mutation types/combinations
were used to parameterize the GoPrime program.
To use GoPrime, users provide a file of their primer/probe sequences (5′-3′ fasta format) and a
file of template sequences to be analyzed (5′-3′ fasta format). GoPrime first analyzes the template,
in both orientations, for possible forward and reverse primer targets (Figure 3); at this stage, forward
and reverse primers are analyzed indivi ually to generate potential targets t investigate fur her as
possible airs. This is done based on th minimum requirements for primer-templat c mplementarity,
which were defined during data analysis (Table 4). Once possible forward and reverse primer targets
are identified, they are evaluated as possible primer pairs (Figure 3). Potential probe targets (optional)
are then identified between the primer pairs, searching again in both orientations based on the
probe-template mismatch limits determined during data analysis (Table 4).
Pathogens 2020, 9, 303 9 of 15
Pathogens 2020, 9, x FOR PEER REVIEW 9 of 15 
 
 
Figure 3. GoPrime flow diagram. GoPrime examines sets of primer sequences (optionally including 
a probe sequence), searches the target genome sequences for potential matches, then predicts the 
effect of any primers/probe-template mismatches present on real-time PCR cycle threshold and limit 
of detection. 
Table 4. The effect of mismatches on ΔCT calculated from the linear model analysis. 
Factor Mismatch Type  ΔCT SE t value p value 
Primer 
% mismatch (forward/reverse combined)* 0.87 0.02 39.39 <0.001 
(minimum of 82.05% match is required [combined % for the pair]) 
nt 1 mismatch (type 1) 1.64 0.24 6.86 <0.001 
2× nt 1 mismatch (type 1) 4.88 0.81 6.02 <0.001 
nt 1 mismatch (type 2) 4.10 0.34 12.03 <0.001 
2× nt 1 mismatch (type 2) 8.71 1.25 6.97 <0.001 
nt 2 mismatch (type 1) 0.90 0.36 2.51 0.012 
2× nt 2 mismatch (type 1) 3.32 0.76 4.40 <0.001 
nt 2 mismatch (type 2) 3.44 0.39 8.82 <0.001 
2× nt 2 mismatch (type 2) 6.13 1.06 5.79 <0.001 
nt 3-4 mismatch (type 1) 1.07 0.40 2.69 0.007 
2× nt 3-4 mismatch (type 1) 2.14**    
nt 3-4 mismatch (type 2) 2.99 0.34 8.79 <0.001 
2× nt 3-4 mismatch (type 2) 4.83 2.97 1.63 0.105 
Maximum of two mismatches can be tolerated in the 3ʹ-ends (within or between primers) 
Probe 
% mismatch 0.50 0.03 18.35 <0.001 
(minimum of 85.00% match is required) 
(nt) nucleotide; (ΔCT) change in cycle threshold; (SE) standard error. For multiple mismatches, the linear model was 
able to calculate the effect of having the same type of mutation in both the primers (2×), if two mismatches were present 
but different the linear model calculated the additive/dampening effect: two 3ʹ-end primer mismatches (ΔCT: −0.27 
[2dp]); one primer and one probe mismatch (ΔCT: +0.43 [2dp]). Mismatches were grouped as one of two types: (type 
1) purine-pyrimidine mismatch (G-T; C-A: minor conformational change in the primer/probe-template duplex); (type 
2) purine-purine or pyrimidine-pyrimidine mismatch (G-A; A-A; G-G; C-T; T-T; C-C: major conformational change in 
the primer/probe-template duplex). One linear model looked primer-template mismatches; a second linear model was 
used to look at probe-template mismatches. *If (for example) a type nt 1 mismatch was present, the percentage 
mismatch ΔCT would be calculated and an additional nt 1 mismatch ΔCT penalty added. ΔCT, SE, and t value given to 
2 decimal places. **Insufficient oligos to calculate with accuracy, therefore GoPrime calculates this based on ΔCT of nt 
3-4 mismatch (type 1) × 2. 
Once a potentially suitable primer and probe set has been identified, GoPrime uses the 
parameters determined in the linear model to predict whether amplification is likely to occur and the 
effect of any mismatches present on ΔCT and ΔLOD, implementing additive/dampening effects of 
multiple mismatches if applicable. GoPrime provides the outputs as two separate text files. Firstly, a 
Figure 3. GoPrime flow diagram. GoPrime exa ines sets of primer sequences (optionally including
a probe sequence), searches the target genome sequences for potential matches, then predicts the
effect of any primers/probe-template mismatches present on real-time PCR cycle threshold and limit
of detection.
Table 4. The effect of misma es on ∆CT calculated from the linear model analysis.
Factor Mismatch Type ∆CT SE t Value p Value
Primer
% mismatch (forward/reverse combined) * 0.87 0.02 39.39 <0.001
(minimum of 82.05% match is required [combined % for the pair])
nt 1 mismatch (type 1) 1.64 0.24 6.86 <0.001
2× nt 1 mismatch (type 1) 4.88 0.81 6.02 <0.001
nt 1 mismatch (type 2) 4.10 0.34 12.03 <0.001
2× nt 1 mismatch (type 2) 8.71 1.25 6.97 <0.001
nt 2 mismatch (type 1) 0.90 0.36 2.51 0.012
2× nt 2 mismatch (type 1) 3.32 0.76 4.40 <0.001
nt 2 mismatch (type 2) 3.44 0.39 8.82 <0.001
2× nt 2 mismatch (type 2) 6.13 1.06 5.79 <0.001
nt 3-4 mismatch (type 1) 1.07 0.40 2.69 0.007
2× nt 3-4 mismatch (type 1) 2.14 **
nt 3-4 mismatch (type 2) 2.99 0.34 8.79 <0.001
2× nt 3-4 mismatc (type 2) 4.83 2.97 1.63 0.105
Maximum of two mi matches can be tolerated in the 3′-ends ( ithin or between rimers)
Probe
% mismatch 0.50 0.03 18.35 <0.001
(minimum of 85.00% match is required)
(nt) nucleotide; (∆CT) change in cycle threshold; (SE) standard error. For multiple mismatches, the linear model was able to
calculate the effect of having the same type of mutation in both the primers (2×), if two mismatches were present but different
the linear model calculated the additive/dampening effect: two 3′-end primer mismatches (∆CT: −0.27 [2dp]); one primer and
one probe mismatch (∆CT: +0.43 [2dp]). Mismatches were grouped as one of two types: (type 1) purine-pyrimidine mismatch
(G-T; C-A: minor conformational change in the primer/probe-template duplex); (type 2) purine-purine or
pyrimidine-pyrimidine mismatch (G-A; A-A; G-G; C-T; T-T; C-C: major conformational change in the primer/probe-template
duplex). One linear model looked primer-template mismatches; a second linear model was used to look at probe-template
mismatches. * If (for example) a type nt 1 mismatch was present, the percentage mismatch ∆CT would be calculated and an
additional nt 1 mismatch ∆CT penalty added. ∆CT, SE, and t value given to 2 decimal places. ** Insufficient oligos to calculate
with accuracy, therefore GoPrime calculates this based on ∆CT of nt 3–4 mismatch (type 1) × 2.
Once a potentially suitable primer and probe set has been identified, GoPrime uses the parameters
determined in the linear model to predict whether amplification is likely to occur and the effect of
any mismatches present on ∆CT and ∆LOD, implementing additive/dampening effects of multiple
mismatches if applicable. GoPrime provides the outputs as two separate text files. Firstly, a simple
analysis, which provides each sequence name against the predicted ∆CT and ∆LOD, number of
mismatches present and the likely amplicon length. The second analysis provides more detail,
including the position and orientation of each likely primer/probe target and number and the type of
any mismatches present (Figure 3, Supplementary Data Figure S2).
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If users have a corresponding phylogenetic tree of their target sequences, they can visualize
the results by using the GoPrimeTree program which will color the tip labels of the tree based on
the GoPrime ∆CT results. In order to use this, users provide the text file output of GoPrime in
addition to a phylogenetic tree (nexus format). GoPrimeTree color codes the sequences according
to the predicted ∆CT, via annotation of the nexus tree file, so that the predicted targets and effect of
the primer/probe-template mismatches can be easily visualized across multiple target sequences in
FigTree [31].
3.3. Evaluating GoPrime as a Predictor of rPCR Performance
Evaluation of GoPrime using the seven DNA oligonucleotide templates containing sequence
variations, observed in naturally occurring FMDV isolates in the Callahan et al. (2002) target region [27]
(Table 3), showed that GoPrime on average predicted the ∆CT of reactions 1.49 (SD 1.20; range 0.01–6.37)
away from the observed result, when looking at all data points across the dilution series (Figure 4).
In addition, GoPrime on average predicted the ∆LOD of reactions 0.63 (range 0.30–1.52) away from the
observed result (Figure 4, Supplementary Data Table S3).
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Figure 4. Evaluating GoPrime as a predictor of real-time PCR (rPCR) performance using naturally
occurring sequence variations. GoPrime predictions are plotted against the (A) observed change in
cycle threshold for ExciteTM UF 2x Master Mix; (B) observed change in cycle threshold for SuperScript™
III Platinum™ One-Step qRT-PCR Kit; (C) observed change in limit of detection for ExciteTM UF
2x Master Mix; (D) observed change in limit of detection for SuperScript™ III Platinum™ One-Step
qRT-PCR Kit. For the observed results, points represent the average change in cycle threshold or limit
of detection across all dilutions (106–100) of the starting template.
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Although GoPrime can only be currently used to evaluate rPCR and two-step rRT-PCR assays
(in which RT and PCR stages are separate and mismatches persist through to cDNA), GoPrime was able
to identify the likely targets for four FMDV-typing assays (East Africa specific for serotypes A, O, SAT 1,
and SAT 2). The targets identified were consistent with previously published results, with each set of
serotype-specific primers identifying the template sequences within their target serotype. However,
cross-reactivity between serotypes was not predicted by GoPrime, which was evident in the published
results [9] (Figure 5, Supplementary Data Figure S4).
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Figure 5. Using GoPrime and GoPrimeTree to predict the likely targets of foot-and-mouth disease virus
(FMDV)-typing PCR assays (Bachanek-Bankowska et al., 2016) (n = 66). Four primer/probe sets were
tested: (A) serotype A; (B) serotype O; (C) serotype S uthern African Territories (SAT) 1; (D) serotype
SAT 2. For the col scheme: (dark green) perfect p imer/probe-template match; (mid-green) cycle
threshold affected by up to a CT f 5; (light green) cycle threshold affected by up to a CT of 10; (black)
sequence predict d not to amplify.
4. Discussion
Primer and/or probe-template mismatches are often unavoidable in rPCR, leading to the
requirement for continual monitoring of oligonucleotides used in assays against available sequence
data, to ensure that assays remain fit for purpose. Consequently, the ability to quantitatively evaluate
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the performance of rPCR primers and probes in silico could aid researchers and diagnosticians by
rapidly predicting the effects of mismatches present on rPCR amplification, which is not possible using
current methods.
The GoPrime framework is currently limited to rPCR (DNA template). For GoPrime to predict the
effect of mismatches on one-step rRT-PCR, where gene-specific primers are used in both the RT and
rPCR stages, further work is required to analyze the effect of mismatches between RNA templates and
primers during the reverse transcription step. Although GoPrime should be applicable to two-step
rRT-PCR, where the use of Oligo(dT) or random hexamers for the RT stage results in primer and
probe-template mismatches persisting from RNA though to cDNA, further analysis is required to
confirm this. Furthermore, our experimental design is currently limited to a single real-time PCR
machine and two PCR kits. With inherent differences between PCR machines and due to different
rRT-PCR kits having previously been shown to differ in their tolerance to mismatches [22], it would
be beneficial to investigate how the general mismatch rules reported are affected by factors such as
equipment performance and assay format.
Empirical data generated in this study were consistent with previous publications: mismatches
in the 3′-end of primers had a more detrimental effect on rPCR amplification than those located
towards the 5′-end, due to disruption of the DNA polymerase active site [11,16,18,20,22]. The effect of
single mismatches within the 3′-end region displayed a consistent pattern, related to both nucleotide
position and mismatch type. The effect of probe-template mismatches also displayed a consistent
pattern, however, further testing and analysis on the positional effects of probe-template mismatches is
required in order for these positional effects to be accurately included within GoPrime, in addition
to probe-template percentage complementarity. For example, mismatches in the center of the probe
have been previously reported to destabilize probe-template annealing [20]. At present, GoPrime
splits mismatches into two types: (type 1) purine-pyrimidine mismatch (G-T or C-A nucleotide base
pairing, leading to a minor conformational change in the primer/probe-template duplex) and (type 2)
purine-purine or pyrimidine-pyrimidine mismatch (G-A, A-A, G-G, C-T, T-T or C-C nucleotide base
pairing, leading to a major conformational change in the primer/probe-template duplex). Furthermore,
the current model of GoPrime looks at the average effect of primer/probe-template mismatches across
all template copy numbers. Future frameworks, to improve accuracy, could consider categorizing
mismatches further and could include the effect of template copy number and PCR efficiency.
With rPCR assays requiring different performance criteria depending upon their use, the ability
of GoPrime to quantitatively predict the effect of primer/probe-template mismatches on both CT and
LOD could help diagnosticians accurately assess whether rPCR assays are fit for their intended use.
For instance, predicting whether assays that aim to differentiate between serotypes are specific to that
serotype. Furthermore, some rPCR assays might give positive results in spite of mismatches when
high viral loads are present (such as in acute stages of disease), but generate a false-negative in the
presence of lower viral loads (such as in oesophageal–pharyngeal fluid or environmental samples for
FMDV). Although the experimental data gained in this study was specific to the rPCR conditions and
primer/probe sequences evaluated, GoPrime predicted the likely positive targets of four FMDV-typing
assays, which target alternative regions of the FMDV genome. However, as cross-reactivity between
serotypes was not predicted, the next stage for analysis would be to include ∆CT data from other assays
and to test the program across other organisms, to analyze GoPrime’s versatility and broaden the
genomic context of the analysis. Furthermore, the analysis for GoPrime is currently based on data from
synthesized DNA oligonucleotides diluted in carrier RNA. Further work is required to ensure that
the general mismatch rules are consistent across clinical samples, which have more complex matrices
including background nucleic acid and mixed DNA populations.
In conclusion, this paper describes the development of GoPrime: a freely available primer
evaluation program which predicts the likely performance of primer/probe sets across multiple
sequence data. Experimental data suggested that mismatch impacts follow a consistent pattern,
enabling GoPrime to be parametrized from experimental observations. Within this study, GoPrime
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was only validated against primers and probes targeting FMDV, and a further research avenue would
be to challenge GoPrime with alternative targets, to ascertain the broader prediction accuracy of
this tool with additional assay targets. By providing a novel quantitative approach to primer/probe
evaluation, GoPrime offers increased flexibility to the user by not only predicting the likely targets
of primer/probe sets, but also estimating the effects of any mismatches present on CT and LOD in
silico, thereby enabling selection of the most appropriate primer/probe combination given the research
question and diagnostic sample.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-0817/9/4/303/s1,
Table S1: Statistical analyses to determine linear model variables; Figure S2: GoPrime example output; Table S3:
Predicted and observed ∆CT and ∆LOD for the linear DNA templates representing FMDV field isolates for testing
GoPrime predictions; Figure S4: Using GoPrime to predict the likely targets of four foot-and-mouth disease virus
(FMDV)-typing RT-PCR assays.
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